Rubedo Life Sciences Announces Phase 1b Data Showing Reduction in Skin Epigenetic Age and Systemic Inflammatory Biomarkers Following Four-Week Treatment with RLS-1496
The atopic dermatitis results were presented at the Aging Research and Drug Discovery (ARDD) conference in Boston on October 2. Clinical findings from the AK program were presented in a late-breaking presentation at the European Academy of Dermatology and Venereology (EADV)…